Human Genome Epidemiology Literature Finder
Records 1 - 24 (of 24 Records) |
Query Trace: Coronary artery disease and CD14[original query] |
---|
Polymorphism in the promoter of lipopolysaccharide receptor CD14 and ischemic cerebrovascular disease. Stroke; a journal of cerebral circulation 2000 Nov 31 (11): 2661-4. Ito D, Murata M, Tanahashi N, Sato H, Sonoda A, Saito I, Watanabe K, Fukuuchi |
CD14 C(-260)-->T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease. Journal of the American College of Cardiology 2002 Jul 40 (1): 34-42. Koenig Wolfgang, Khuseyinova Natalie, Hoffmann Michael M, März Winfried, Fröhlich Margit, Hoffmeister Albrecht, Brenner Hermann, Rothenbacher Dietri |
CD14 gene -159C/T polymorphism is not associated with coronary artery disease and myocardial infarction. American heart journal 2002 Jun 143 (6): 971-6. Koch Werner, Kastrati Adnan, Mehilli Julinda, von Beckerath Nicolas, Schömig Albe |
C(-260)T polymorphism in the promoter of the CD14 gene is not associated with coronary artery disease and myocardial infarction in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. The American journal of cardiology 2002 Dec 90 (11): 1249-52. Nauck Markus, Winkelmann Bernhard R, Hoffmann Michael M, Böhm Bernhard O, Wieland Heinrich, März Winfri |
The C(-260)>T gene polymorphism in the promoter of the CD14 monocyte receptor gene is not associated with acute myocardial infarction. Clinical and experimental medicine 2003 Nov 3 (3): 161-5. Longobardo M T, Cefalù A B, Pezzino F, Noto D, Emmanuele G, Barbagallo C M, Fiore B, Monastero R, Castello A, Molini V, Notarbartolo A, Travali S, Averna M |
Association study of CD14 polymorphism with myocardial infarction in a Japanese population. Japanese heart journal 2003 Sep 44 (5): 613-22. Hohda Shigeru, Kimura Akinori, Sasaoka Taishi, Hayashi Takeharu, Ueda Kazuo, Yasunami Michio, Okabe Masaaki, Fukuta Naoto, Kurosawa Toshiro, Izumi Toh |
CD14 promoter polymorphism -159C>T is associated with susceptibility to chronic Chlamydia pneumoniae infection in peripheral blood monocytes. Genes and immunity 2004 Aug 5 (5): 435-8. Rupp J, Goepel W, Kramme E, Jahn J, Solbach W, Maass |
Pharmacogenetics of the CD14 endotoxin receptor polymorphism and progression of coronary atherosclerosis. Thrombosis and haemostasis 2004 May 91 (5): 986-90. Agema Willem R P, Wouter Jukema J, de Maat Moniek P M, Zwinderman Aeilko H, Kastelein John J P, Rabelink Ton J, van der Wall Ernst |
CD14 C(-260)T promoter polymorphism and prevalence of acute coronary syndromes. International journal of cardiology 2005 Feb 98 (2): 307-12. Arroyo-Espliguero Ramón, El-Sharnouby Khaled, Vázquez-Rey Eugenia, Kalidas Kamini, Jeffery Steve, Kaski Juan Carl |
Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery disease. The American journal of cardiology 2006 Nov 98 (9): 1182-4. Bernardo Esther, Angiolillo Dominick J, Ramírez Celia, Cavallari Ugo, Trabetti Elisabetta, Sabaté Manel, Hernández Rosana, Moreno Raul, Escaned Javier, Alfonso Fernando, Bañuelos Camino, Costa Marco A, Bass Theodore A, Pignatti Pier Franco, Macaya Carlos, Fernandez-Ortiz Anton |
CD14 gene polymorphism 159C/T in a group of patients with coronary artery disease from a population with high morbidity of cardiovascular diseases. Kardiologia polska 2007 Mar 65 (3): 237-44; discussion 245. Rechci?ski Tomasz, Grebowska Aneta, Kurpesa Ma?gorzata, Peruga Zbigniew, Dziuba Micha?, Krzemi?ska-Paku?a Maria, Rudnicka Wies?awa, Chmiela Magdale |
Association between inflammatory gene polymorphisms and coronary artery disease in an Indian population. Journal of thrombosis and thrombolysis 2009 Jan 27 (1): 88-94. Banerjee Indranil, Pandey Umeshwar, Hasan Omer M, Parihar Rashmi, Tripathi Vijaya, Ganesh Subramani |
Inflammatory response of coronary artery disease postmenopausal women is associated with the IVS1-397T > C estrogen receptor alpha polymorphism. Clinical immunology (Orlando, Fla.) 2009 Mar 130 (3): 355-64. My?liwska Jolanta, Rutkowska Aleksandra, Hak Lukasz, Siebert Janusz, Szyndler Krzysztof, Racho? Domin |
CD14 promoter polymorphism (- 159C-->t) is not associated with myocardial infarction or coronary artery disease in patients with assumed high genetic risk. The Thoracic and cardiovascular surgeon 2009 Oct 57 (7): 386-90. Haberbosch W, Unkelbach K, Schuster D, Gardemann A, Tillmanns H, Hölschermann |
Role of the CD14 C(-260)T promoter polymorphism in determining the first clinical manifestation of coronary artery disease. Journal of cardiovascular medicine (Hagerstown, Md.) 2010 Jan 11 (1): 20-5. Rizzello Vittoria, Liuzzo Giovanna, Trabetti Elisabetta, Di Giannuario Giovanna, Brugaletta Salvatore, Santamaria Matteo, Piro Maddalena, Boccanelli Alessandro, Pignatti Pier Franco, Biasucci Luigi M, Crea Filip |
Genetic variation in the adiponectin receptor 2 (ADIPOR2) gene is associated with coronary artery disease and increased ADIPOR2 expression in peripheral monocytes. Cardiovascular diabetology 2010 9 (1): 10. Halvatsiotis Iosif, Tsiotra Panayoula C, Ikonomidis Ignatios, Kollias Anastasios, Mitrou Panagiota, Maratou Eirini, Boutati Eleni, Lekakis John, Dimitriadis George, Economopoulos Theofanis, Kremastinos Dimitrios T, Raptis Sotirios |
Is evaluation of complex polymorphism helpful in the assessment of prognosis after percutaneous coronary intervention. A prospective study. Kardiologia polska 2011 69 (9): 881-8. Rywik Tomasz M, Szperl Ma?gorzata, P?oski Rafa?, Leszek Przemys?aw, Roszczynko Marta, Rynkun Dariusz, Witkowski Adam, Kurjata Pawe?, Korewicki Jer |
Genetic polymorphisms of TP53 and FAS promoter modulate the progression of coronary artery disease after coronary artery bypass grafting: a gender-specific view. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2011 May 60 (5): 439-45. Beiras-Fernandez A, Angele M K, Koutang C, Lohse P, Reichart B, Lohse P, Eifert |
CRP and CD14 polymorphisms correlate with coronary plaque volume in patients with coronary artery disease--IVUS substudy of the ENCORE trials. Atherosclerosis 2012 Jan 220 (1): 172-6. Hermann Matthias, Fischer Dieter, Hoffmann Michael M, Gasser Theo, Quitzau Kurt, Meinertz Thomas, Münzel Thomas, Lüscher Thomas |
A Multinomial Ordinal Probit Model with Singular Value Decomposition Method for a Multinomial Trait. Journal of probability and statistics 2012 2012 . Kwon Soonil, Goodarzi Mark O, Taylor Kent D, Cui Jinrui, Chen Y-D Ida, Rotter Jerome I, Hsueh Willa, Guo Xiuqi |
Polymorphism of stromal cell-derived factor-1 selectively upregulates gene expression and is associated with increased susceptibility to coronary artery disease. Biochemical and biophysical research communications 2014 Jan 443 (3): 932-7. Gu Xiao-Long, Ma Na, Xiang Ding-Cheng, Huang Jun, Dong Zheng-Hua, Lei Hui-Yan, Ding Ru, Gong Zhi-Hua, Wen Yan-Fei, Qiu Jian, Ma L |
TLR-4 and CD14 Genotypes and Soluble CD14: Could They Predispose to Coronary Atherosclerosis? Journal of cardiovascular development and disease 2016 Mar 3 (1): . Konstantinidou Maria Kalliopi, Goutas Nikos, Vlachodimitropoulos Dimitrios, Chaidaroglou Antigoni, Stefanou Demetrios, Poumpouridou Nikoleta, Mastorakou Renata, Gazouli Maria, Kyparissopoulos Dimitrios, Spiliopoulou Cha |
Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General Population. Arteriosclerosis, thrombosis, and vascular biology 2017 Oct . Antiochos Panagiotis, Marques-Vidal Pedro, Virzi Julien, Pagano Sabrina, Satta Nathalie, Hartley Oliver, Montecucco Fabrizio, Mach François, Kutalik Zoltan, Waeber Gerard, Vollenweider Peter, Vuilleumier Nicol |
Association of COL4A1 (rs605143, rs565470) and CD14 (rs2569190) genes polymorphism with coronary artery disease. Molecular and cellular biochemistry 2018 Jan . Raza Syed Tasleem, Abbas Shania, Eba Ale, Karim Fazal, Wani Irshad Ahmad, Rizvi Saliha, Zaidi Alina, Mahdi Farza |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: